Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 98 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?Rayner, C.; Horowitz, M.
2001Prevalence of Gastrointestinal Symptons Associated with Diabetes Mellitus: A Population-Based Surevy of 15000 AdultsBytzer, P.; Talley, N.; Leemon, M.; Young, L.; Jones, M.; Horowitz, M.
1995Effect of short term starvation on gastric emptying in normal and obese subjects - Relationship to oral glucose toleranceCorvilain, B.; Abramowicz, M.; Fery, F.; Schoutens, A.; Verlinden, M.; Balasse, E.; Horowitz, M.
1996Appetite regulation by carbohydrate: role of blood glucose and gastrointestinal hormones.Lavin, J.; Wittert, G.; Sun, W.M.; Horowitz, M.; Morley, J.; Read, N.
2020Acute effects of whey protein on energy intake, appetite and gastric emptying in younger and older, obese menOberoi, A.; Giezenaar, C.; Jensen, C.; Lange, K.; Hausken, T.; Jones, K.L.; Horowitz, M.; Chapman, I.; Soenen, S.
2020Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptyingHorowitz, M.; Rayner, C.K.; Marathe, C.S.; Wu, T.; Jones, K.L.
2014Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjectsPlummer, M.; Jones, K.; Annink, C.; Cousins, C.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
1998Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate1–3Lavin, J.; Wittert, G.; Andrews, J.; Yeap, B.; Wishart, J.; Morris, H.; Morley, J.; Horowitz, M.; Read, N.
2014Incretins and the intensivist: what are they and what does an intensivist need to know about them?Plummer, M.; Chapman, M.; Horowitz, M.; Deane, A.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.